Influence of hormonal replacement therapy on risk of human papilloma virus infection

Bogdan Waksmański; Kazimierz Kamiński; Małgorzata Cieślak-Steć

Abstract

2/2002 vol. 1

Influence of hormonal replacement therapy on risk of human papilloma virus infection

Bogdan Waksmański

,

Kazimierz Kamiński

,

Małgorzata Cieślak-Steć

(Prz Menopauz 2002, 2: 42–48)

Online publish date: 2004/03/03

View full text

AMA

Waksmański B, Kamiński K, Cieślak-Steć M. Influence of hormonal replacement therapy on risk of human papilloma virus infection. Menopause Review/Przegląd Menopauzalny. 2002;1(2):42-48.

APA

Waksmański, B., Kamiński, K., & Cieślak-Steć, M. (2002). Influence of hormonal replacement therapy on risk of human papilloma virus infection. Menopause Review/Przegląd Menopauzalny, 1(2), 42-48.

Chicago

Waksmański, Bogdan, Kazimierz Kamiński, and Małgorzata Cieślak-Steć. 2002. "Influence of hormonal replacement therapy on risk of human papilloma virus infection". Menopause Review/Przegląd Menopauzalny 1 (2): 42-48.

Harvard

Waksmański, B., Kamiński, K., and Cieślak-Steć, M. (2002). Influence of hormonal replacement therapy on risk of human papilloma virus infection. Menopause Review/Przegląd Menopauzalny, 1(2), pp.42-48.

MLA

Waksmański, Bogdan et al. "Influence of hormonal replacement therapy on risk of human papilloma virus infection." Menopause Review/Przegląd Menopauzalny, vol. 1, no. 2, 2002, pp. 42-48.

Vancouver

Waksmański B, Kamiński K, Cieślak-Steć M. Influence of hormonal replacement therapy on risk of human papilloma virus infection. Menopause Review/Przegląd Menopauzalny. 2002;1(2):42-48.

Share

Coverage in

Indexed in

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications